作者:Hui Xu、Wu-Qing Liu、Ling-Ling Fan、Yang Chen、Liu-Meng Yang、Lei Lv、Yong-Tang Zheng
DOI:10.1248/cpb.56.720
日期:——
Eight simple N-arylindoles were designed, synthesized and evaluated as human immunodeficiency virus (HIV)-1 integrase inhibitors in vitro for the first time. Among these compounds, 3b, 3e and 3g demonstrated significant anti-HIV-1 integrase activity. Especially 3b showed the highest anti-HIV-1 integrase activity with EC50 value of 7.88 μg/ml and TI value of 24.61. Meantime, some structure–activity relationships were also observed and will provide a new lead for design and discovery of more potent N-arylindoles as HIV-1 integrase inhibitors.
研究人员设计、合成了八个简单的 N-芳基吲哚,并首次在体外将其作为人类免疫缺陷病毒(HIV)-1 整合酶抑制剂进行了评估。在这些化合物中,3b、3e 和 3g 具有显著的抗 HIV-1 整合酶活性。其中,3b的EC50值为7.88 μg/ml,TI值为24.61,具有最高的抗HIV-1整合酶活性。同时,还观察到了一些结构-活性关系,这将为设计和发现更强的 N-芳基吲哚作为 HIV-1 整合酶抑制剂提供新的线索。